Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended		17 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022
Cash flows from operating activities:
Net loss	$ (18,482,143)	$ (19,393,896)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of right-of-use assets		86,847
Stock-based compensation expense	2,124,261	2,900,124
Non-cash interest expense associated with the sale of future royalties	3,605,293	2,907,895	$ 9,932,614
Changes in operating assets and liabilities
Prepaid expenses and other current assets	1,161,538	1,072,687
Accounts payable	(333,486)	598,083
Accrued expenses and other current liabilities	923,460	781,016
Operating lease liabilities, current		(94,941)
Net cash used in operating activities	(11,001,077)	(11,142,185)
Cash flows from financing activities:
Fees paid in connection with the reverse stock split fractional shares	(5)
Proceeds from the sale of future royalties		60,000,000
Net cash (used in) provided by financing activities	(5)	60,000,000
Net (decrease) increase in cash, cash equivalents and restricted cash	(11,001,082)	48,857,815
Cash, cash equivalents and restricted cash
Beginning of period	60,855,080	25,456,952
End of period	49,853,998	74,314,767	49,853,998
Reconciliation of the Condensed Consolidated Statements of Cash Flows to the Condensed Consolidated Balance Sheets
Cash and cash equivalents	49,753,998	74,214,767	49,753,998
Restricted cash	100,000	100,000	100,000
Total cash, cash equivalents and restricted cash	$ 49,853,998	$ 74,314,767	$ 49,853,998